Stay updated on Pembrolizumab for HNSCC Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for HNSCC Residual Disease Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added the disease term 'Squamous cell carcinoma of the head and neck' and a Resources entry for Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T05:35:51.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed. This appears to be a technical site update with no changes to trial content.
    Difference
    0.1%
    Check dated 2026-03-18T20:19:27.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:23:08.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Deleted the government funding lapse notice and related operating-status information (Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T10:20:06.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added a site-wide notice about funding-related status and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:39:26.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The changes are minor UI and metadata updates, including a glossary toggle, updated QC-related labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and removal of older labels. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:38:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for HNSCC Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.